Boehringer Ingelheim, Inc., the US subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally in 45 countries with nearly 36,000 employees. The company is committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicines.

Below is a sampling of Boehringer Ingelheim's medicinal products: